Bristol-Myers Squibb
Quality Improvement Initiative in Subcutaneous Immuno-Oncology Applicant Guide
Pages
3
Time to read
6 mins
Publication
Language
English
Pages
3
Time to read
6 mins
Publication
Language
English
This document is an applicant guide for the Quality Improvement Initiative in Subcutaneous Immuno-Oncology (QI3-SC). It outlines the purpose of the initiative, which is to support healthcare organizations in adapting to the increasing use of subcutaneous immuno-oncology agents. The guide details the eligibility criteria for applicants, who must be healthcare professionals involved in the delivery of care to cancer patients treated with subcutaneous immune checkpoint inhibitors. It specifies that projects must focus on quality improvement and workflow transformation, with funding available for new projects or new aspects of existing projects. The guide also provides important dates for the application process, including the launch of the Request for Proposal and the application deadline. Additionally, it describes the funding conditions, including the maximum amount available and the requirements for project evaluation and reporting. The document emphasizes that research proposals are not eligible for funding and outlines the review process for submitted applications.